logo
Lawrence Summers: This Law Made Me Ashamed of My Country

Lawrence Summers: This Law Made Me Ashamed of My Country

New York Times08-07-2025
Last week, Robert Rubin and I warned of the many macroeconomic risks created by the domestic policy bill President Trump signed into law on Friday. I stand by our judgment that it will most likely slow growth, risk a financial crisis, exacerbate trade deficits and undermine national security by exhausting the government's borrowing capacity. This is more than ample reason to regret its passage.
I want to return to the topic after conversations with health professionals, including my daughters, who practice medicine and social work in rural New Hampshire. They made me realize that a focus on macroeconomics, while valid, misses the human brutality that I now see as the most problematic aspect of the legislation. I don't remember on any past Fourth of July being so ashamed of an action my country had just taken.
Over the holiday weekend, while the president was celebrating tax cuts that over 10 years will deliver an average of more than $1 million to families in the top 0.1 percent of the income distribution, medical professionals were considering questions like these:
What should they say to seriously disabled patients, who can live at home only because Medicaid pays for rides to their medical appointments, now that those people could lose that coverage?
What should they recommend to the relatives caring for poor patients at home, who will no longer be able to work when payments for home-health aides are no longer be available?
How should they advise the hospital to handle patients who can't afford rehab or nursing facilities and can't live at home, but who currently occupy rooms desperately needed by acutely ill patients?
Should they still feel proud of and committed to the work of giving comfort to the lonely, poor and elderly, when their country's leaders has decided that more money for the most fortunate is a higher priority?
How can they face patients who will be evicted from the hospital with perhaps as little as a cab voucher when their stays end?
After we talked about these questions, it occurred to me to think about precedents in American history — other moments when the social safety net was cut — to see what followed. Did the feared consequences materialize? Were errors corrected?
I am plenty negative about this president and this moment. Even I was unpleasantly surprised by what I learned.
This round of budget cuts in Medicaid far exceeds any other cut the United States has made in its social safety net. The approximately $1 trillion reduction, over 10 years, represents about 0.3 percent of gross domestic product. Previously, the most draconian cuts came with President Ronald Reagan's 1981 tax law. But they were far smaller — $12 billion over 10 years and 0.03 percent of G.D.P. The Trump law will remove more than 11 million people from the rolls, compared with about three million under the Reagan cuts. Other noteworthy reductions to the social safety net, such as the Clinton-era welfare reform, were even smaller.
Because Medicaid is a state-level program and varies widely across the country, economists can evaluate the impact of alternative policies. A number of studies suggest that removing one million people from the rolls for one year could result in about 1,000 additional deaths. It follows that removing more than 11 million people for a decade would likely result in more than 100,000 deaths. Because this figure fails to take account of the degradation of service to those who remain eligible — fewer rides to the hospital, less social support — it could well be an underestimate.
Want all of The Times? Subscribe.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Health insurer Centene reports surprise quarterly loss
Health insurer Centene reports surprise quarterly loss

Yahoo

time17 minutes ago

  • Yahoo

Health insurer Centene reports surprise quarterly loss

(Reuters) -Centene on Friday reported a surprise quarterly loss after the health insurer warned of a revenue slump from government-backed plans, sending its shares down nearly 3% in premarket trading. "We are disappointed by our second-quarter results, but we have a clear understanding of the trends that have impacted our performance, and are working with urgency and focus to restore our earnings trajectory," CEO Sarah London said. The health insurance industry has seen elevated medical costs and changing enrollment patterns, at a time when it braces for big spending cuts and rule changes under the Trump administration. Earlier this month, Centene withdrew its 2025 earnings forecast due to an expected revenue slump from commercial plans under Affordable Care Act, also known as Obamacare. These plans offer a sliding scale of government subsidies based on income. For the second quarter, the health insurer reported adjusted loss per share of 16 cents, compared to analysts estimates of a profit of 86 cents per share, according to data compiled by LSEG.

Stock market today: Dow, S&P 500, Nasdaq futures hit pause after record-setting rally
Stock market today: Dow, S&P 500, Nasdaq futures hit pause after record-setting rally

Yahoo

time17 minutes ago

  • Yahoo

Stock market today: Dow, S&P 500, Nasdaq futures hit pause after record-setting rally

US stock futures steadied near all-time highs on Friday as investors assessed a packed week of major earnings, trade deals, and President Trump's unusual visit to the Federal Reserve. Dow Jones Industrial Average futures (YM=F) ticked up 0.1%, while S&P 500 futures (ES=F) traded flat on the heels of notching its fourth record close in a row thanks to hopes for AI growth. Contracts on the tech-heavy Nasdaq 100 (NQ=F) were also little changed. Markets are hitting pause on the recent risk-on rally that has seen the S&P 500 (^GSPC) and Nasdaq Composite (^IXIC) stack up records, setting the major gauges on track for weekly gains of around 1%. Spirits got a boost from a US-Japan trade pact that boosted optimism for more deals, while blue-chip and Big Tech results underpinned a solid start to earnings season. But some on Wall Street are questioning whether FOMO — "fear of missing out" — is driving gains, rather than fundamentals. Investors may now be locking in profits ahead of a big week bringing the Fed's two-day policy meeting, the monthly US jobs report, and a flood of quarterly results highlighted by Apple (AAPL), Meta (META), Microsoft (MSFT), and Meta (META). Most of all, it features the Aug. 1 deadline for countries to strike trade deals with the US or face "reciprocal" tariff hikes — with major trading partner the European Union yet to agree terms. Read more: The latest on Trump's tariffs Meanwhile, Trump has downplayed the risk of Jerome Powell being ousted as Fed chair, easing market concerns about upheaval at the central bank. The president visited the Fed's headquarters on Thursday to tour its $2.5 billion renovation project. He has criticized the project as too expensive, sparking speculation he might use it as a pretext to try to fire Powell. However, Trump indicated he wasn't considering firing the Fed chair. "To do that is a big move, and I just don't think it's necessary," he said. Intel reported its earnings after the bell Thursday, beating Wall Street expectations on revenue. The company's stock turned negative, however, as CEO Lip-Bu Tan discussed layoffs and the cancelation of some factory plans. Read more: Full earnings coverage in our live blog Intel stock slides amid plans to cut 15% of workforce, cancel factories Intel (INTC) shares slid almost 6% in premarket after the struggling chipmaker said it will cut its workforce and drop plans for factories in Europe as it pursues a comeback. While the company posted a second quarter revenue beat late Thursday, its earnings fell short. Its profit forecast for the current quarter was also more downbeat than hoped: It expects to break even, rather than deliver the $0.04 earnings per share estimated. Yahoo Finance's Daniel Howley reports: Read more here. Oil prices climbed overnight Thursday, driven by renewed optimism over global trade negotiations, which bolstered confidence in economic growth and energy demand. The wave of positivity managing to overshadow concerns about a possible increase in Venezuelan oil supply. Reuters reports: Read more here. Intel stock slides amid plans to cut 15% of workforce, cancel factories Intel (INTC) shares slid almost 6% in premarket after the struggling chipmaker said it will cut its workforce and drop plans for factories in Europe as it pursues a comeback. While the company posted a second quarter revenue beat late Thursday, its earnings fell short. Its profit forecast for the current quarter was also more downbeat than hoped: It expects to break even, rather than deliver the $0.04 earnings per share estimated. Yahoo Finance's Daniel Howley reports: Read more here. Intel (INTC) shares slid almost 6% in premarket after the struggling chipmaker said it will cut its workforce and drop plans for factories in Europe as it pursues a comeback. While the company posted a second quarter revenue beat late Thursday, its earnings fell short. Its profit forecast for the current quarter was also more downbeat than hoped: It expects to break even, rather than deliver the $0.04 earnings per share estimated. Yahoo Finance's Daniel Howley reports: Read more here. Oil prices climbed overnight Thursday, driven by renewed optimism over global trade negotiations, which bolstered confidence in economic growth and energy demand. The wave of positivity managing to overshadow concerns about a possible increase in Venezuelan oil supply. Reuters reports: Read more here. Oil prices climbed overnight Thursday, driven by renewed optimism over global trade negotiations, which bolstered confidence in economic growth and energy demand. The wave of positivity managing to overshadow concerns about a possible increase in Venezuelan oil supply. Reuters reports: Read more here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Health insurer Centene reports surprise loss on rising medical costs
Health insurer Centene reports surprise loss on rising medical costs

Yahoo

time17 minutes ago

  • Yahoo

Health insurer Centene reports surprise loss on rising medical costs

(Reuters) -Centene on Friday posted a surprise quarterly loss, partly hurt by higher medical costs related to its insurance plans, sending its shares tumbling nearly 13% in premarket trading. The health insurance industry has seen elevated medical costs and changing enrollment patterns, at a time when it braces for big spending cuts and rule changes under the Trump administration. "We are disappointed by our second-quarter results, but we have a clear understanding of the trends that have impacted our performance, and are working with urgency and focus to restore our earnings trajectory," CEO Sarah London said. Rivals Elevance and Molina Healthcare have also warned of elevated costs in government-backed insurance plans. Centene reported a medical cost ratio, the percentage of premiums spent on medical care, of 93% in the second quarter, compared with analysts' expectation of 89.34%. The increase was driven by a reduction in net 2025 marketplace risk adjustment revenue as well as higher medical costs in Medicaid, driven mainly by behavioral health, home health and high-cost drugs. Earlier this month, Centene withdrew its 2025 earnings forecast due to an expected revenue slump from commercial plans under Affordable Care Act, also known as Obamacare. These plans offer a sliding scale of government subsidies based on income. For the second quarter, the health insurer reported adjusted loss per share of 16 cents, compared to analysts estimates of a profit of 86 cents, according to data compiled by LSEG.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store